Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Triple Negative Breast Neoplasms × Brentuximab Vedotin × 30 days × Clear all

Sponsor

Conditions

Hodgkin Disease 2 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Carcinoma, Non-Small-Cell Lung 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

pembrolizumab 19 Specimen Handling 12 Magnetic Resonance Spectroscopy 11 Paclitaxel 10 Carboplatin 10 Biopsy 10 olaparib 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 eribulin 4 Taxes 4 Capecitabine 4 X-Rays 3 Nivolumab 3 Doxorubicin 3 Cisplatin 3 tucatinib 2 sargramostim 2 liposomal doxorubicin 2 durvalumab 2 ceralasertib 2 Trastuzumab 2 Standard of Care 2 Platinum 2 Immunoglobulin G 2 Fulvestrant 2 Drug Therapy 2 Docetaxel 2 Cyclophosphamide 2 Colony-Stimulating Factors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡